Protocol No.: V212-011; "A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor or Hematologic Malignancy"

  • Markowitz, Avi, (PI)

    Project: Other project

    StatusFinished
    Effective start/end date6/13/1112/31/16

    Funding

    • Merck Sharp & Dohme Corporation: $78,042.85